Skip to content
Review Open access

The Battle Between Japanese Encephalitis Virus and Host Innate Immune System: Evasion and Response

Sep 2026 · Viruses · Vol 18, pp. 975 · 0 citations · 107 references
Medicine

TL;DR

This review will focus on the innate immune response to JEV infection and the viral immune evasion strategies, such as escaping recognition or inhibiting the production of antiviral factors.

Abstract

Japanese encephalitis (JE) is a natural zoonotic disease caused by the Japanese encephalitis virus (JEV), which poses potential threats to human health and the pig farming industry. To establish infection, JEV must overcome the innate immune responses and complete its lifecycle in new hosts. Notably, the direct virus-induced neuronal cell death and an uncontrolled neuroinflammatory response jointly lead to the pathogenesis of JEV. In this review, we will focus on the innate immune response to JEV infection and the viral immune evasion strategies, such as escaping recognition or inhibiting the production of antiviral factors. Generally, JEV exploits four innate immune pathways, including type I interferon, interleukins, programmed cell death, and autophagy, to facilitate self-replication or exacerbate disease. Moreover, host microRNAs modulated during JEV infection have emerged as key regulators of this virus–host interplay. Therefore, a full understanding of how the immune system reacts to JEV infection and how the virus evades innate immune clearance will help develop effective vaccines or antiviral therapies.

Read PDF

Similar papers

Review Open access Sep 2026

Hantavirus: biology, immune responses, and pathogenesis

This review synthesizes the recent research on hantavirus biology, cellular entry mechanisms, and epidemiological characteristics, and highlights that viral immune evasion and subsequent uncontrolled host immune responses act as the core pathogenic drivers.

Yu-Fang Shi, Mauro Piacentini, A. Zumla et al. · 0 citations
Review Open access Sep 2026

Zika virus and host innate immunity: mechanisms of activation and evasion

This Review summarizes current knowledge of how the innate immune system recognizes ZIKV and how the virus counteracts these responses, while highlighting unresolved questions and potential therapeutic targets.

Dan-Yu Qian, Yu-Lei Guo, Ai-Xin Li et al. · 0 citations
Review Open access Aug 2026

Innate immunity-mediated inflammation and immunopathogenesis in HSV-1-infected encephalitis.

HSV-1 encephalitis (HSE) remains a devastating viral infection of the central nervous system despite effective antiviral therapy. Increasing evidence indicates that disease outcome is not determined by viral replication alone but by how innate immunity is calibrated within the brain. Studies of host susceptibility in c...

Sheng Yang, Yang-Kun Shen, Chunfu Zheng · 1 citation
Review Open access Sep 2026

Host Genetic Susceptibility and Antiviral Immunity Shape the Pathogenesis and Outcomes of Herpes Simplex Encephalitis

Simple Summary Herpes simplex encephalitis (HSE) is the most common sporadic viral encephalitis worldwide. Even with antiviral therapy, it remains life-threatening and often leaves survivors with severe neurological deficits. Although herpes simplex virus (HSV) infection is extremely common, only a tiny fraction of inf...

Yu-Fei Zhan, Jing Li, Qiao-Ling Yuan et al. · 0 citations
Review Sep 2026

Modulation of host cellular antiviral responses by arthropod-transmitted RNA viruses.

Arboviruses encompass a diverse spectrum of arthropod-transmitted RNA viruses that pose an extensive threat to human health and the economy. These obligate intracellular pathogens induce severe pathologies by strategically subverting the host's innate immune responses, often leading to a plethora of clinical manifestat...

Priyanshu Walia, Gaurav Gunwal, S. Choudhary et al. · 0 citations
Aug 2026

Lineage-specific pulmonary transcriptome landscape of coronavirus infection unveils universal immunotherapy for viral pneumonia.

It is demonstrated that a rational combination of pharmacological targeting of innate and adaptive immune responses is sufficient to reduce mortality and severe illness caused by beta, delta and EG.1 variants in SARS-CoV-2 infection.

Ming Zhou, Xuan Liu, Haiqing Xiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.